Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2004 > Volume 13 Number 5 September 2004 > AORTIC VALVE DISEASE > Effects of Valve Replacement on Left Ventricular Function in Patients with Aortic Regurgitation and Severe Ventricular Disease

Effects of Valve Replacement on Left Ventricular Function in Patients with Aortic Regurgitation and Severe Ventricular Disease

Julian Collinson, Marcus Flather, John R. Pepper, Michael Henein
Clinical Trials and Evaluation Unit, Department of Echocardiography, Department of Cardiac Surgery, Royal Brompton and Harefield NHS Trust and National Heart and Lung Institute, London UK

Background and aim of the study: Longstanding aortic regurgitation (AR) can result in left ventricular (LV) dysfunction that may reverse after aortic valve replacement (AVR). Stentless valves may result in a more rapid recovery in function due to a more physiological flow and lower outflow resistance.
Methods: The effect of AVR on LV function was studied in 47 patients who received either a stentless (n = 33) or stented (n = 14) valve for isolated AR. All patients had evidence of pre-existing LV dysfunction (end-systolic dimension (ESD) >50 mm). Patients were studied using transthoracic echocardiography at baseline, postoperatively, and at 2.5-year follow up.
Results: Preoperatively, there were no differences in LV dimensions. The end-diastolic dimension fell from 75 ± 10 mm to 61 ± 10 mm postoperatively and to 52 ± 10 mm at follow up in the stentless group (p <0.001), and ESD fell from 54 ± 10 mm to 36 ± 8 mm at follow up (p <0.001). There were no significant

early changes in patients who received stented valves, though LV dimensions fell at follow up. Fractional shortening (FS) increased from 25 ± 8% in the postoperative period to 31 ± 7% in the stentless group (p <0.001), but there was no change in the stented group (20 ± 7% versus 23 ± 8%). In the stentless group, LV mass fell from 366 ± 104 g to 276 ± 68 g postoperatively and to 219 ± 79 g at follow up (p <0.001); there was no postoperative change in the stented group, though a late reduction occurred, from 349 ± 51 g preoperatively to 265 ± 61 g at follow up (p = 0.06).
Conclusion: For patients with AR and LV dysfunction, AVR with a stentless prosthesis offers early reductions in LV dimensions, improved LV function, and regression of LV mass. In patients who received a stented valve, these improvements were delayed and less complete. Hence, for some patients with AR and LV dysfunction, a stentless prosthesis may be preferable.
The Journal of Heart Valve Disease 2004;13:722-728

Effects of Valve Replacement on Left Ventricular Function in Patients with Aortic Regurgitation and Severe Ventricular Disease

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.